Goldman Sachs Group Inc Tricida, Inc. Put Options Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

May 14, 2024
BUY
$8.51 - $13.6 $416,139 - $665,040
48,900 New
48,900 $512,000
Q3 2022

Nov 10, 2022
BUY
$8.51 - $13.6 $416,139 - $665,040
48,900 New
48,900 $512,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email